You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 3, January 21, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (33)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Dermatology
 •Pathology & Laboratory Medicine
 •Bites and Stings
 •Alert me on articles by topic

Tick Bites and Lyme Disease in an Endemic Setting

Problematic Use of Serologic Testing and Prophylactic Antibiotic Therapy

Alan D. Fix, MD, MS; G. Thomas Strickland, MD, PhD; John Grant, MD, MPH

JAMA. 1998;279:206-210.

Context.— The use of serologic testing to diagnose Lyme disease (LD) is a source of controversy. Expert recommendations also discourage the routine use of antibiotic therapy for prophylaxis of LD following tick bites, but the extent to which physicians in endemic areas have adopted these recommendations is not known.

Objective.— To assess the pattern of use of serologic testing and antibiotic therapy for tick bites and LD and associated charges for management in an endemic area.

Design.— Active surveillance of patient-physician encounters for tick bites and LD.

Setting.— Primary care practices on the Eastern Shore of Maryland.

Patients.— Consecutive sample of 232 patients with tick bites, LD (defined by physician diagnosis in medical record), and suspected LD (physician notation of possible, but not definite LD) seen in 1995.

Main Outcome Measures.— Serologic testing for LD, test results, antibiotic therapy, and direct costs of management.

Results.— Surveillance identified 142 patients (61.2%) with diagnoses of tick bites, 40 patients (17.2%) with LD, and 50 patients (21.6%) with suspected LD. Of the 142 patients seen for tick bites, 95 (67%) underwent serologic testing for LD. Of these, 93 patients had initial negative or equivocal results; 24 (26%) of the 93 had convalescent testing, with 1 seroconversion. Seventy-eight patients (55%) with a diagnosis of tick bite received antibiotic therapy. No patients with tick bite developed clinical LD. Serologic testing for LD was performed for 36 patients (90%) with a diagnosis of LD and 46 patients (92%) with suspected LD. In most cases, antibiotics were prescribed before serologic test results became available. Convalescent testing was not performed for 37 (86%) of the 43 patients with suspected LD who had initial negative or equivocal results. Of these 37 patients, 25 (68%) did not receive antibiotic therapy. Direct charges for treatment of these 232 patients totaled $47595, one third of which was attributable to serologic testing. A total of 32% of direct charges were for patients with tick bites, 48% were for patients with LD, and 20% were for patients with suspected LD.

Conclusions.— In this setting, most patients consulting physicians for tick bites received prophylactic antibiotic therapy of unproven efficacy and underwent unnecessary, costly serologic testing. Despite almost universal use in this study, serologic testing for LD did not appear to influence treatment of patients diagnosed as having LD.


From the Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Md (Drs Fix and Strickland), and the Kent County Health Department, Chestertown, Md (Dr Grant).


RELATED ARTICLE

Expert Advice and Patient Expectations: Laboratory Testing and Antibiotics for Lyme Disease
Alan G. Barbour
JAMA. 1998;279(3):239-240.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antibiotic Prophylaxis for Lyme Disease: How the Way of Reporting a Clinical Trial Can Alter the Perception of Effectiveness
Gonzalez
Arch Dermatol 2003;139:373-375.
FULL TEXT  

Doxycycline for Tick Bites -- Not for Everyone
Shapiro
NEJM 2001;345:133-134.
FULL TEXT  

Prevention of Lyme Disease
Committee on Infectious Diseases
Pediatrics 2000;105:142-147.
ABSTRACT | FULL TEXT  

Billions for Defense: The Pervasive Nature of Defensive Medicine
Anderson
Arch Intern Med 1999;159:2399-2402.
FULL TEXT  

Role of Serology in the Diagnosis of Lyme Disease
Brown et al.
JAMA 1999;282:62-66.
ABSTRACT | FULL TEXT  

Tick-Borne Pulmonary Disease: Update on Diagnosis and Management
Faul et al.
Chest 1999;116:222-230.
ABSTRACT | FULL TEXT  

Diagnosis, Treatment, and Prevention of Lyme Disease
Bransfield et al.
JAMA 1998;280:1049-1051.
FULL TEXT  

Mismanagement of Tick Bites
JWatch Emergency Med. 1998;1998:15-15.
FULL TEXT  

Managing Tick Bites Where Lyme Disease Is Endemic
JWatch Infect. Diseases 1998;1998:2-2.
FULL TEXT  

Lyme Disease Confusion Abounds
Journal Watch Dermatology 1998;1998:13-13.
FULL TEXT  

LYME DISEASE CONFUSION ABOUNDS
JWatch General 1998;1998:2-2.
FULL TEXT  

Expert Advice and Patient Expectations: Laboratory Testing and Antibiotics for Lyme Disease
Barbour
JAMA 1998;279:239-240.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.